Resistance to Acetaminophen Interference in a Novel Continuous Glucose Monitoring System
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Acetaminophen (APAP) can cause erroneously high readings in real-time continuous glucose monitoring (rtCGM) systems. APAP-associated bias in an investigational rtCGM system (G6) was evaluated by taking the difference in glucose measurements between rtCGM and YSI from 1 hour before to 6 hours after a 1-g oral APAP dose in 66 subjects with type 1 or type 2 diabetes. The interference effect was defined as the average post-dose (30-90 minutes) bias minus the average baseline bias for each subject. The clinically meaningful interference effect was defined as 10 mg/dL. The G6 system’s overall mean (±SD) interference effect was 3.1 ± 4.8 mg/dL (one-sided upper 95% CI = 4.1 mg/dL), significantly lower than 10 mg/dL. The G6 system’s resistance to APAP interference should provide reassurance to those using the drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Review of Acetaminophen Poisoning
Hodgman, M. J., & Garrard, A. R. (2012) · Critical Care Clinics · doi:10.1016/j.ccc.2012.07.006 · Cited by 314
Continuous Glucose Monitor Interference With Commonly Prescribed Medications: A Pilot Study
Basu, A., Slama, M. Q., Nicholson, W. T., Langman, L., Peyser, T., Carter, R., & Basu, R. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817697329 · Cited by 77 · cited 5×
“Real-time and intermittently scanned CGM systems that rely on electrochemical sensors, such as the Dexcom G4, Dexcom G5, MiniMed Sof-Sensor, Medtronic Enlite, and Abbott FreeStyle Libre, can be subject to varying degrees of interference from several medications and nondrug compounds, including acetaminophen, salicylat…”
BackgroundInfluential
Cited by
Electrochemical glucose sensors in diabetes management: an updated review (2010–2020)
Teymourian, H., Barfidokht, A., & Wang, J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00304b · Cited by 881
One year clinical experience of the first commercial hybrid closed-loop system
Lal, R. A., Basina, M., Maahs, D. M., Hood, K., Buckingham, B., & Wilson, D. M. (2019) · Diabetes Care · doi:10.2337/dc19-0855 · Cited by 215
Shah, V. N., Laffel, L. M., Wadwa, R. P., & Garg, S. K. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0143 · Cited by 197
Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline
Galindo, R. J., Umpierrez, G. E., Rushakoff, R. J., Basu, A., Lohnes, S., Nichols, J. H., Spanakis, E. K., Espinoza, J., Palermo, N. E., Awadjie, D. G., et al. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820954163 · Cited by 170
Galindo, R. J., Aleppo, G., Klonoff, D. C., Spanakis, E. K., Agarwal, S., Vellanki, P., Olson, D. E., Umpierrez, G. E., Davis, G. M., & Pasquel, F. J. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820932903 · Cited by 155
“24 A recently recognized interference by hydroxyurea has also been noted with the G6, and the manufacturer has recommended discontinuation of the CGM in patients using this medication.”
Metadata
- Authors
- Calhoun, P., Johnson, T. K., Hughes, J., Price, D., & Balo, A. K.
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2018-01-16
- Volume
- 12
- Issue
- 2
- Pages
- 393-396
- ISSN
- 1932-2968 (ISSN-L)
- OpenAlex
- W2784330150
- Cited by
- 58
- References
- 2
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Resistance to Acetaminophen Interference in a Novel Continuous Glucose Monitoring System. https://app.cochat.ai/papers/10.1177/1932296818755797
- The paper
- Calhoun, P., Johnson, T. K., Hughes, J., Price, D., & Balo, A. K. (2018). Resistance to Acetaminophen Interference in a Novel Continuous Glucose Monitoring System. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296818755797
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.